Eptifibatide
Product Images NDC 14335-070

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 14335-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C1fc3a9b 57d5 6bcb E053 2995a90a6dac

C1fc3a9b 57d5 6bcb E053 2995a90a6dac
This is a description of a pharmaceutical product called Eptifibatide Injection. It is manufactured by Hanan ol Pham Co. L. and distributed by Siste Run Pramsceuicas, LLC. The solution is contained in a 100 mL vial and the concentration is 75 mg/100 mL (0.75 mg/mL). It is used only for intravenous (IV) infusion and is intended for weight-adjusted dosages. The solution contains 0.75 mg of eptifibatide, 5.25 mg of sodium chloride, and water. It must be refrigerated and has a shelf life of 24 months. After transfer to room temperature, it must be used within 2 months. The lot number is I 101. The usual dosage information is contained in the accompanying package insert.*
FDA Label Image

C1fc3c67 A777 6c84 E053 2995a90af6ac

C1fc3c67 A777 6c84 E053 2995a90af6ac
This is a description of a medicine. It includes the name of the product, the manufacturer, and the recommended dosage for intravenous use. The text also provides information about the size and temperature storage requirements of the medication, as well as instructions to protect it from light and to discard it at the appropriate time.*
FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Principal Display Panel (20 mg Carton Label)

Principal Display Panel (20 mg Carton Label)
This appears to be a combination of a few different items such as a product label, dosing instructions, and storage information. There are mentions of medication names such as Eptifibatide and Gulinyang Economic Development. However, without more context, it is difficult to determine the exact purpose or context of this text.*
FDA Label Image

Principal Display Panel (75 mg Carton Label)

Principal Display Panel (75 mg Carton Label)
This is a description of a medication, Eptifibatide Injection supplied in a 75 mg/100 mL single-dose vial for weight-adjusted infusion. The medication is manufactured by Hanan ol Pham Co. L. and distributed by Siste Run Pramsceuicas, LLC. The usual dosage and storage information are provided and it is important to note that the medication must be refrigerated and should not be used beyond 2 months. It is intended for intravenous use only and should be administered under proper medical guidance. The NDC number is 1433507101.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.